Moreover, Io et al demonstrated the protective effect of suberoylanilide hydroxamic acid (SAHA), a class I HDAC inhibitor similar to VPA, on the progression of peritoneal fibrosis in mice[14]. This evidence concerns the gene HDAC9 and Peritoneal Fibrosis.